Innovation developed in Luxembourg – The Minister of Economy visiting Flen Health
Esch-sur-Alzette, 30th July 2020: Together with the Minister of Economy, Franz Fayot, Flen Health’s CEO, Philippe Sollie and Flen Health’s VP R&D, Gilles Brackman reflected on how the BioHealth sector in Luxembourg has developed over the previous years and what role Flen Health has played and will play towards Luxembourg’s BioHealth.
Since 2011 Flen Health’s headquarters have been located in Luxembourg. In 2017 the medical device and biotechnology company secured an important R&D fund provided by the Ministry of Economy of the Grand Duchy of Luxembourg and an additional loan supplied by the EFSI. Flen Health was able to grow its R&D work force and also able to work on several R&D projects that supported the development of innovative biotechnologies.
“Flen Health is grateful for the financial aid it receives from government bodies and commits to use that aid responsibly to realise its mission. Our mission is clear and hasn`t changed since I founded the company in 2000. Flen Health develops innovation that helps people around the world, with infectious and inflammatory disorders, live the life they love”, says Philippe Sollie.
In total Flen Health secured over €2.5 million non-dilutive funding over the past two & half years and has over €8 million non-dilutive funding pending this year, not only in Europe but also in the US.
“With a new promising project, that we would like to realise in Luxembourg, aimed at integrative treatment development, we will significantly change how wounds are treated. These disruptive technologies are being developed in our in-house facilities as well as in collaboration with research centres in Europe and the USA. But our mission is not only to develop innovative technologies but also to support in building a more inclusive community, support social and economic growth”, explains Gilles Brackman.
About Flen Health
Flen Health believes biotech innovation can help to build a securer life for all of us. With its product portfolio, Flen Health aims to improve the quality of life of people suffering from inflammatory or infectious skin diseases in a responsible way by providing added value for patients, healthcare professionals and health authorities.